HQY

Nasdaq

HEALTHEQUITY, INC.

Latest disclosureSeptember 18, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 7 sales

Price by TradingView

Insider transactions 45

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Showing the first 6 of 7 trades on this page.

Sale disclosed

Adrian T. Dillon

Director

Common Stock

Reported value: $658.17K
Reported price: $104.4718 / share

Sale disclosed

Adrian T. Dillon

Director

Common Stock

Reported value: $140.2K
Reported price: $105.2557 / share

Sale disclosed

Michael Henry Fiore

EVP, CHIEF COMMERCIAL OFFICER

Common Stock

Reported value: $223.63K
Reported price: $95.00 / share

Sale disclosed

Michael Henry Fiore

EVP, CHIEF COMMERCIAL OFFICER

Common Stock

Reported value: $234.65K
Reported price: $95.00 / share

Sale disclosed

Michael Henry Fiore

EVP, CHIEF COMMERCIAL OFFICER

Common Stock

Reported value: $298.49K
Reported price: $95.00 / share

Sale disclosed

Gayle Furgurson Wellborn

Director

Common Stock

Reported value: $219.51K
Reported price: $90.00 / share

Sale disclosed

Delano Ladd

EVP, General Counsel

Common Stock

Reported value: $675K
Reported price: $90.00 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
Director	Common StockSale10b5-12 trades	7,632avg $104.61 / share	$798.37K	Aug 25Filed Aug 27 · 2d later	2 filings 6,300 @ $104.47 · $658.17KSEC filing 1,332 @ $105.26 · $140.2KSEC filing
EVP, CHIEF COMMERCIAL OFFICER	Common StockSale10b5-1	2,354$95.00 / share	$223.63K	Jul 10Filed Jul 14 · 4d later	SEC filing
EVP, CHIEF COMMERCIAL OFFICER	Common StockSale10b5-1	2,470$95.00 / share	$234.65K	Jul 2Filed Jul 7 · 5d later	SEC filing
EVP, CHIEF COMMERCIAL OFFICER	Common StockSale10b5-1	3,142$95.00 / share	$298.49K	May 29Filed Jun 2 · 4d later	SEC filing
Director	Common StockSale10b5-1	2,439$90.00 / share	$219.51K	May 28Filed Jun 1 · 4d later	SEC filing
EVP, General Counsel	Common StockSale10b5-1	7,500$90.00 / share	$675K	May 28Filed Jun 1 · 4d later	SEC filing

Congress transactions 3

All Congress filings

Purchase disclosed

HealthEquity, Inc. - Common Stock (HQY) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: July 10, 2026

Purchase disclosed

HealthEquity, Inc. - Common Stock (HQY) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 30, 2026

Purchase disclosed

HealthEquity, Inc. - Common Stock (HQY) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 29, 2026

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0001428336
Latest public acceptance: Sep 18, 2026, 09:30 PM UTC
Score calculated: Oct 8, 2026, 12:06 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

Director

Common StockSale10b5-12 trades

7,632avg $104.61 / share

$798.37K

Aug 25Filed Aug 27 · 2d later

2 filings

6,300 @ $104.47 · $658.17KSEC filing
1,332 @ $105.26 · $140.2KSEC filing

EVP, CHIEF COMMERCIAL OFFICER

Common StockSale10b5-1

2,354$95.00 / share

$223.63K

Jul 10Filed Jul 14 · 4d later

SEC filing

EVP, CHIEF COMMERCIAL OFFICER

Common StockSale10b5-1

2,470$95.00 / share

$234.65K

Jul 2Filed Jul 7 · 5d later

SEC filing

EVP, CHIEF COMMERCIAL OFFICER

Common StockSale10b5-1

3,142$95.00 / share

$298.49K

May 29Filed Jun 2 · 4d later

SEC filing

Director

Common StockSale10b5-1

2,439$90.00 / share

$219.51K

May 28Filed Jun 1 · 4d later

SEC filing

EVP, General Counsel

Common StockSale10b5-1

7,500$90.00 / share

$675K

May 28Filed Jun 1 · 4d later

SEC filing

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0001428336
Latest public acceptance: Sep 18, 2026, 09:30 PM UTC
Score calculated: Oct 8, 2026, 12:06 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.